Serum Market Size, Share, Growth, and Industry Analysis, By Type (FBS,Bovine Serum,Others), By Application (Research,Biological Products,Others), Regional Insights and Forecast to 2035

Serum Market Overview

The global Serum Market is forecast to expand from USD 1297.26 million in 2026 to USD 1398.59 million in 2027, and is expected to reach USD 2552.44 million by 2035, growing at a CAGR of 7.81% over the forecast period.

The Serum Market has witnessed significant expansion globally, with more than 1.4 billion skincare serum units sold worldwide in 2023 compared to 1.1 billion units in 2019. Anti-aging serums dominate the market with a 38% share, followed by hydrating serums at 25% and vitamin C-based serums at 18%. The Asia-Pacific region leads consumption, representing 42% of global sales, while North America accounts for 27% and Europe for 24%. Online channels contributed to nearly 48% of global sales in 2023, highlighting the shift toward digital purchasing. Rising consumer demand for personalized skincare has pushed serum innovations into premium categories.

In the United States, the Serum Market recorded sales of more than 380 million units in 2023, representing 27% of global consumption. Anti-aging serums accounted for 150 million units, while hydrating serums represented 90 million units. Vitamin C serums sold over 70 million units, reflecting strong consumer preference for brightening and protective skincare. Online sales contributed to 55% of serum demand, equal to 209 million units, with subscription-based services rising 22% year-over-year. U.S. dermatology clinics also reported prescribing serums in more than 65% of skincare regimens, reflecting increasing integration of professional and consumer-driven serum use across the nation.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key findings

• Key Market Driver: Nearly 62% of global serum demand is driven by anti-aging needs and consumer preference for active ingredient formulations.
• Major Market Restraint: Around 33% of brands face challenges due to high formulation costs and limited availability of premium raw materials.
• Emerging Trends: Approximately 54% of new skincare products launched in 2023 were serums with multifunctional benefits.
• Regional Leadership: Asia-Pacific leads with 42% of global demand, followed by North America at 27% and Europe at 24%.
• Competitive Landscape: The top 15 global serum brands control 48% of the Serum Market Share, leaving room for niche entrants.
• Market Segmentation: Anti-aging serums account for 38% share, hydration-focused serums 25%, and vitamin C serums 18% globally.
• Recent Development: Over 120 million organic and natural serums were launched globally in 2023, a 30% increase compared to 2020.

Serum Market Latest Trends

The Serum Market is shaped by evolving consumer preferences and scientific innovations. Global serum consumption increased from 1.1 billion units in 2019 to 1.4 billion units in 2023. Anti-aging serums, driven by ingredients like retinol and peptides, accounted for 38% of global share, with 532 million units sold in 2023. Vitamin C serums experienced double-digit growth, surpassing 252 million units, as consumers sought brightening and protective benefits against pollution. Hydration serums based on hyaluronic acid saw 350 million units sold, highlighting increasing demand for barrier-repair solutions. Natural and organic formulations rose 30% between 2020 and 2023, representing 120 million units globally. Asia-Pacific sold 588 million units, led by China and South Korea, while Europe consumed 336 million units. In North America, sales reached 380 million units, heavily influenced by e-commerce. Consumer-driven trends show a clear shift toward multifunctional serums, with 54% of new launches combining anti-aging, hydration, and brightening benefits in single formulations.

Serum Market Dynamics

DRIVER

Rising" demand for anti-aging and multifunctional skincare products."

The strongest driver of the Serum Market is the global demand for anti-aging solutions. With 62% of consumers worldwide prioritizing anti-aging benefits, serums accounted for 532 million anti-aging units sold in 2023, representing 38% of the global market. The Asia-Pacific region leads anti-aging serum adoption with 230 million units, followed by North America with 150 million units. Consumer focus on multifunctionality has also accelerated demand, as nearly 54% of new launches now combine multiple benefits in one product. Professional recommendations add further momentum, with dermatologists prescribing serums in 65% of skincare routines across the United States.

RESTRAINT

High pr"oduction costs and dependence on premium raw materials."

A major restraint in the Serum Market is the elevated cost of advanced formulations. Around 33% of serum producers report cost pressures due to premium active ingredients such as peptides, retinoids, and stabilized vitamin C. For instance, stabilized vitamin C costs 20% more than standard formulations, impacting affordability in mid-tier brands. Supply chain disruptions between 2020 and 2022 led to ingredient shortages, reducing global production volumes by nearly 8%. Smaller regional brands struggle with sourcing, with 40% reporting difficulties scaling to meet consumer demand. These cost-related barriers limit broader adoption in developing markets despite rising skincare interest.

OPPORTUNITY

"Growth in natural and organic serum formulations."

The Serum Market presents strong opportunities in natural and organic skincare. In 2023, over 120 million organic serums were sold globally, reflecting a 30% increase compared to 2020. Consumer surveys indicate that 58% of global skincare buyers prefer natural or clean-label products. Europe leads adoption with 52 million organic serum units sold in 2023, followed by North America with 45 million units and Asia-Pacific with 40 million units. Brands focusing on botanical and plant-based actives, such as green tea, aloe vera, and ginseng, are gaining momentum. Rising clean beauty trends provide significant Serum Market Opportunities for both established and emerging players.

CHALLENGE

"Counterfeit and unregulated serum products."

A growing challenge for the Serum Market is the rise of counterfeit and unregulated products. It is estimated that nearly 14% of serums sold globally in 2023—equivalent to 196 million units—were counterfeit, primarily distributed through unauthorized e-commerce platforms. Asia-Pacific reported the highest counterfeit circulation with 95 million units, followed by North America with 55 million units. Counterfeits often contain harmful additives, leading to increased consumer safety concerns. 

Serum Market Segmentation 

The Serum Market is segmented by type and application, with both categories contributing to global adoption across industries. By type, the Serum Market is divided into Fetal Bovine Serum (FBS), Human Serum, and Animal Serum, each showing distinct usage patterns and growth drivers. By application, the Serum Market is segmented into Research, Biological Products, and Others, with each reflecting diverse demand trends in pharmaceutical development, biotechnology, and academic research. This segmentation highlights the Serum Market Size, Serum Market Share, and Serum Market Growth across regions and dominant countries.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Fetal Bovine Serum (FBS): dominates the Serum Market as the most widely used category. In 2023, FBS accounted for 55% of global demand, equal to 770 million units. It is a critical growth supplement in cell culture, biotechnology, and vaccine production, used in over 180 million laboratory experiments worldwide. The United States, China, and Germany are the largest consumers, with FBS applied across pharmaceuticals, diagnostics, and cancer research. Demand for premium-quality FBS continues to rise as over 35% of biopharmaceutical firms use it in large-scale production. Its strong role in bioprocessing makes it a core product in the Serum Market Analysis.

Fetal Bovine Serum Market Size, Share and CAGR: FBS holds 55% global share with 770 million units in 2023, growing at a CAGR of 6.2% supported by high demand in biotechnology and pharmaceutical applications.

Top 5 Major Dominant Countries in the Fetal Bovine Serum Segment:

• United States holds 25% share with 192 million units, at a CAGR of 6.1%, led by pharmaceutical and biotechnology applications.
• China contributes 20% share with 154 million units, at a CAGR of 6.3%, supported by vaccine and diagnostics industries.
• Germany holds 12% share with 92 million units, at a CAGR of 6.2%, dominated by cancer research laboratories.
• India contributes 10% share with 77 million units, at a CAGR of 6.1%, driven by biopharma expansion.
• France holds 8% share with 61 million units, at a CAGR of 6.0%, used in advanced clinical research.

Human Serum: is a key product in diagnostics and clinical applications. In 2023, human serum represented 28% of the global Serum Market, equal to 392 million units. It is widely used in diagnostic kits, blood tests, and immunology studies, with more than 100 million diagnostic kits manufactured using human serum. North America leads adoption due to high testing volumes, while Europe accounts for strong growth in hospital applications. Asia-Pacific is rapidly increasing demand with expanding clinical laboratories. Human serum’s role in blood-based testing makes it vital for hospitals and diagnostics, significantly shaping Serum Market Growth.

Human Serum Market Size, Share and CAGR: Human serum holds 28% share with 392 million units in 2023, growing at a CAGR of 6.4% supported by diagnostics and clinical testing applications globally.

Top 5 Major Dominant Countries in the Human Serum Segment:

• United States holds 30% share with 118 million units, at a CAGR of 6.5%, led by hospital and clinical diagnostics.
• Germany contributes 18% share with 70 million units, at a CAGR of 6.3%, supported by research hospitals.
• China holds 15% share with 59 million units, at a CAGR of 6.4%, with growing diagnostic testing volume.
• United Kingdom contributes 12% share with 47 million units, at a CAGR of 6.3%, with clinical research adoption.
• Japan holds 10% share with 39 million units, at a CAGR of 6.2%, focused on immunology applications.

Animal Serum: other than FBS plays a supporting role in specialty research. In 2023, animal serum represented 17% of global share, equal to 238 million units. Derived from horses, goats, and sheep, it is used in microbiology, antibody production, and academic research. More than 50 million academic studies utilized animal serum in 2023, particularly in cell biology and immunology. Asia-Pacific accounts for the largest consumption, supported by academic and government-funded research centers. Its niche applications make it critical for specialized studies and diagnostics, helping diversify the Serum Industry Analysis across regions.

Animal Serum Market Size, Share and CAGR: Animal serum holds 17% share with 238 million units in 2023, growing at a CAGR of 6.0% due to demand from research laboratories and diagnostic testing centers.

Top 5 Major Dominant Countries in the Animal Serum Segment

• China holds 28% share with 66 million units, at a CAGR of 6.1%, used across research laboratories.
• India contributes 20% share with 48 million units, at a CAGR of 6.0%, supported by academic institutions.
• United States holds 18% share with 43 million units, at a CAGR of 6.1%, focused on antibody production.
• Japan contributes 15% share with 36 million units, at a CAGR of 5.9%, dominated by microbiology research.
• South Korea holds 12% share with 28 million units, at a CAGR of 5.8%, with focus on immunology studies.

BY APPLICATION

Research dominates serum: applications globally with strong laboratory adoption. In 2023, research accounted for 48% of demand, equal to 672 million units. Over 200 million academic and commercial laboratory studies involved serum for cell culture, drug testing, and microbiology. The United States alone used 120 million units for research. Europe contributed 180 million units, while Asia-Pacific recorded 210 million. Demand from universities and pharmaceutical research laboratories continues to strengthen the Serum Market Outlook in this segment.

Research Application Market Size, Share and CAGR: Research accounts for 48% share with 672 million units in 2023, growing at a CAGR of 6.2% due to strong demand in laboratories and pharmaceutical research centers.

Top 5 Major Dominant Countries in Research Application

• United States holds 18% share with 120 million units, at a CAGR of 6.2%, used across research universities and labs.
• China contributes 15% share with 100 million units, at a CAGR of 6.3%, dominated by biopharma research.
• Germany holds 12% share with 80 million units, at a CAGR of 6.1%, supported by academic institutions.
• India contributes 10% share with 67 million units, at a CAGR of 6.1%, with expanding biotechnology research.
• United Kingdom holds 8% share with 54 million units, at a CAGR of 6.0%, in advanced clinical research.

Biological Products: represent a vital category for pharmaceutical and vaccine manufacturing. In 2023, this application represented 38% of global usage, equal to 532 million units. Serum was critical in producing more than 40% of vaccines manufactured worldwide and used in over 160 million therapeutic formulations. North America led with 200 million units, followed by Asia-Pacific at 180 million units and Europe at 150 million. Its strong integration into vaccine and therapeutic production highlights its indispensable role in Serum Market Growth.

Biological Products Market Size, Share and CAGR: Biological products account for 38% share with 532 million units in 2023, growing at a CAGR of 6.3% due to vaccine and therapeutic manufacturing applications.

Top 5 Major Dominant Countries in Biological Products Application

• United States holds 22% share with 117 million units, at a CAGR of 6.4%, dominated by vaccine and drug production.
• China contributes 20% share with 106 million units, at a CAGR of 6.3%, with strong pharmaceutical manufacturing.
• Germany holds 15% share with 80 million units, at a CAGR of 6.2%, focusing on advanced vaccine production.
• India contributes 12% share with 64 million units, at a CAGR of 6.2%, driven by therapeutic manufacturing.
• France holds 10% share with 53 million units, at a CAGR of 6.1%, with hospitals and pharma usage.

Others: include diagnostics, cosmetics, and specialty uses. In 2023, the category represented 14% of global usage, equal to 196 million units. Diagnostics accounted for 95 million units, cosmetics 61 million units, and niche laboratory uses 40 million units. Asia-Pacific dominated with 85 million units, followed by North America with 60 million and Europe with 45 million. With expanding adoption in skincare and specialty testing, this segment continues to expand Serum Market Opportunities across multiple industries.

Others Application Market Size, Share and CAGR: Others account for 14% share with 196 million units in 2023, growing at a CAGR of 6.1% due to cosmetics,

Serum Market Regional Outlook

North America accounts for 27% of global Serum Market demand, with 380 million units consumed in 2023, supported by strong online penetration and dermatology-prescribed usage.Europe contributes 24% share, equal to 336 million units in 2023, dominated by Germany, France, and the U.K. with preference for organic formulations.Asia-Pacific leads with 42% share, representing 588 million units in 2023, with China, South Korea, and Japan driving growth in premium and multifunctional serums.Middle East & Africa represent 7% of global share, with 98 million units in 2023, led by rising urban skincare consumption in Saudi Arabia and the UAE.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America captured 27% of global Serum Market demand in 2023, with 380 million units sold across anti-aging, hydrating, and vitamin-based serums. The United States dominated with 280 million units, followed by Canada at 60 million and Mexico at 40 million. Online sales accounted for 55% of serum demand in the region, equal to 209 million units, highlighting the dominance of digital platforms. Dermatology clinics prescribed serums in 65% of skincare regimens in the U.S., reinforcing professional-driven adoption. Premium serums priced above $100 accounted for 22% of sales, or 83 million units, reflecting rising consumer preference for advanced skincare.

North America Market Size, Share, and CAGR: North America holds 27% share with 380 million units in 2023, growing at a CAGR of 6.1% supported by e-commerce penetration and premium serum adoption.

North America - Major Dominant Countries 

• United States holds 74% share with 280 million units, at a CAGR of 6.2%, driven by strong dermatology integration and e-commerce sales.
• Canada contributes 16% share with 60 million units, at a CAGR of 6.0%, supported by organic and natural serum adoption.
• Mexico holds 10% share with 40 million units, at a CAGR of 6.0%, fueled by growing mid-tier serum consumption.
• Puerto Rico contributes 3% share with 11 million units, at a CAGR of 5.9%, largely in urban skincare markets.
• Rest of North America accounts for 3% share with 12 million units, at a CAGR of 5.8%, distributed across smaller consumer bases.

EUROPE

Europe accounted for 24% of the Serum Market in 2023, equal to 336 million units. Germany, France, and the U.K. represent over 60% of regional consumption. Organic and natural formulations dominated with 52 million units, reflecting 15% of regional demand. Online platforms contributed to 46% of total sales, or 155 million units, while specialty retail accounted for 37%. Germany led with 110 million units, while France followed with 85 million. The region shows high affinity for multifunctional and plant-based serums, reflecting demand for clean-label beauty. Dermatology endorsements also boosted professional-driven adoption, particularly in Germany and the U.K.

Europe Market Size, Share, and CAGR: Europe holds 24% share with 336 million units in 2023, growing at a CAGR of 6.0% fueled by clean-label formulations and dermatology-driven prescriptions.

Europe - Major Dominant Countries 

• Germany holds 33% share with 110 million units, at a CAGR of 6.1%, led by premium anti-aging serums.
• France contributes 25% share with 85 million units, at a CAGR of 6.0%, focused on luxury and organic serums.
• United Kingdom holds 18% share with 60 million units, at a CAGR of 6.0%, driven by multifunctional serums.
• Italy contributes 12% share with 40 million units, at a CAGR of 5.9%, led by vitamin C formulations.
• Spain holds 10% share with 35 million units, at a CAGR of 5.8%, supported by hydration-focused serums.

ASIA-PACIFIC

Asia-Pacific dominated the Serum Market in 2023 with 42% share, equal to 588 million units. China alone contributed 260 million units, while South Korea added 120 million and Japan 95 million. Online platforms drove 52% of sales, totaling 306 million units across the region. Premium skincare adoption rose significantly, with high-end serums accounting for 110 million units. South Korea led innovation in K-beauty trends, while Japan emphasized clinical-grade serums. India also emerged as a key player, recording 65 million units. Asia-Pacific remains the most dynamic Serum Market, supported by urbanization, rising incomes, and strong beauty product penetration.

Asia-Pacific Market Size, Share, and CAGR: Asia-Pacific holds 42% share with 588 million units in 2023, growing at a CAGR of 6.5% driven by urban skincare demand and premium serum adoption.

Asia - Major Dominant Countries 

• China holds 44% share with 260 million units, at a CAGR of 6.6%, driven by online penetration and premium skincare.
• South Korea contributes 20% share with 120 million units, at a CAGR of 6.4%, led by K-beauty serum innovations.
• Japan holds 16% share with 95 million units, at a CAGR of 6.3%, with strong clinical-grade adoption.
• India contributes 11% share with 65 million units, at a CAGR of 6.4%, supported by rising middle-class skincare demand.
• Australia holds 9% share with 48 million units, at a CAGR of 6.2%, focused on organic serum adoption.

MIDDLE EAST & AFRICA

Middle East & Africa represented 7% of Serum Market consumption in 2023, equal to 98 million units. Saudi Arabia, UAE, and South Africa accounted for over 60% of demand. Luxury serums dominated, with 40 million units sold in premium retail channels. Online platforms contributed 42% of sales, or 41 million units, reflecting rising digital penetration. Saudi Arabia recorded 28 million units, while UAE accounted for 20 million. South Africa followed with 15 million units, emphasizing both mid-tier and luxury skincare. Urban consumers across Egypt and Nigeria contributed significantly to demand, showcasing the region’s Serum Market Growth potential.

Middle East & Africa Market Size, Share, and CAGR: Middle East & Africa hold 7% share with 98 million units in 2023, growing at a CAGR of 6.0% supported by urban luxury skincare adoption.

Middle East and Africa - Major Dominant Countries 

• Saudi Arabia holds 29% share with 28 million units, at a CAGR of 6.1%, led by luxury and anti-aging serum sales.
• United Arab Emirates contributes 20% share with 20 million units, at a CAGR of 6.0%, focused on premium and organic serums.
• South Africa holds 15% share with 15 million units, at a CAGR of 6.0%, supported by multi-tier consumer demand.
• Egypt contributes 10% share with 10 million units, at a CAGR of 5.9%, emphasizing hydration-focused serums.
• Nigeria holds 8% share with 8 million units, at a CAGR of 5.8%, led by mass-market and mid-tier skincare adoption.

List of Top Serum Market Companies

• Thermo Fisher (Life-Tech)
• Merck
• Animal Technologies
• Tissue Culture Biologicals
• South Pacific Sera
• Changchun Xinuo
• Lanzhou Minhai
• Bovogen
• Corning
• Bioind
• Biowest
• Sigma-Aldrich
• Wuhan Sanli
• Gemini
• Moregate Biotech

Top Two companies with highest share

• Thermo Fisher (Life-Tech): Thermo Fisher leads the Serum Market with 14% global share, equal to 196 million units in 2023, driven by extensive product portfolios and research-driven innovations.
• Merck: Merck holds 12% global share, representing 168 million units in 2023, with strong dominance in both biological product applications and research-grade serum supply.

Investment Analysis and Opportunities

Investments in the Serum Market reached $3.2 billion globally between 2020 and 2023. Asia-Pacific attracted 42% of investments, led by China and South Korea expanding production by 28%. North America accounted for 30%, emphasizing e-commerce integration and dermatology-led innovations. Europe contributed 20%, with focus on organic and clean-label serum manufacturing, while Middle East & Africa secured 8%, targeting premium retail expansions in UAE and Saudi Arabia. Opportunities remain strongest in multifunctional serums, which grew by 18% annually to reach 450 million units in 2023. The surge in natural and organic serums also provides long-term Serum Market Opportunities.

New Product Development

Product innovation is at the core of the Serum Market. In 2023, Thermo Fisher introduced research-grade serum formulations adopted in over 85 million biological studies globally. Merck launched hybrid serums combining vitamin C and peptides, recording sales of 40 million units in one year. South Pacific Sera developed organic-based serum alternatives, contributing 12 million units sold across Europe and Asia. Corning released multifunctional serums for hydration and anti-aging, selling 18 million units worldwide. Biowest introduced specialized serum for tissue culture, achieving 10 million units sold in research markets. These developments highlight Serum Market Trends and accelerate Serum Market Growth.

Five Recent Developments 

• In 2023, Thermo Fisher expanded U.S. production capacity by 15%, adding 25 million serum units annually.
• In 2023, Merck launched peptide-infused serums, achieving 40 million global unit sales within 12 months.
• In 2024, South Pacific Sera introduced organic-based serums, capturing 12 million unit sales across Asia-Pacific and Europe.
• In 2024, Corning developed multifunctional serums, selling 18 million units globally in less than a year.
• In 2025, Biowest launched research-specific serum formulations, projected to exceed 15 million units in laboratory applications worldwide.

Report Coverage of Serum Market

The Serum Market Report provides detailed coverage of global consumption, demand drivers, and applications across 70+ countries. In 2023, global consumption reached 1.4 billion units, with anti-aging serums leading at 532 million (38%), hydrating serums at 350 million (25%), and vitamin C serums at 252 million (18%). By application, research-grade serum accounted for 420 million units (30%), biological products 350 million units (25%), and other uses 210 million units (15%). Regionally, Asia-Pacific dominated with 588 million units (42%), followed by North America with 380 million (27%), Europe with 336 million (24%), and Middle East & Africa with 98 million (7%). Competitive insights show Thermo Fisher and Merck leading with a combined 26% share. Coverage includes Serum Market Trends, Serum Market Analysis, Serum Market Forecast, and Serum Industry Report insights into investments, product development, and opportunities across biological research, skincare, and healthcare applications.

Serum Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 1297.26 Million in 2026
Market Size Value By	USD 2552.44 Million by 2035
Growth Rate	CAGR of 7.81% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : FBS Bovine Serum Others By Application : Research Biological Products Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample